Business Description
Octopus Biosafety
ISIN : FR0013310281
Total Employee Number:
10Compare
Compare
Traded in other countries / regions
MLOCT.FranceOCR.Germany IPO Date
2019-01-22Description
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | -1.34 | |||||
Debt-to-Equity | -0.83 | |||||
Debt-to-EBITDA | -0.65 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -19.94 | |||||
Beneish M-Score | -8.12 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -38.3 | |||||
3-Year EBITDA Growth Rate | 28.4 | |||||
3-Year EPS without NRI Growth Rate | 49.8 | |||||
3-Year Book Growth Rate | 34.6 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.31 | |||||
Quick Ratio | 0.31 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 349.95 | |||||
Days Sales Outstanding | 305.34 | |||||
Days Payable | 343.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -53.9 | |||||
Shareholder Yield % | -0.85 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -646.15 | |||||
Operating Margin % | -1036.54 | |||||
Net Margin % | -1267.31 | |||||
EBITDA Margin % | -1609.62 | |||||
ROA % | -104.6 | |||||
ROIC % | -80.62 | |||||
3-Year ROIIC % | -47.85 | |||||
ROC (Joel Greenblatt) % | -804.81 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 45 | |||||
EV-to-EBIT | -27.97 | |||||
EV-to-EBITDA | -27.97 | |||||
EV-to-Revenue | 450.13 | |||||
Price-to-GF-Value | 2.5 | |||||
Earnings Yield (Greenblatt) % | -3.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Octopus Biosafety Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.052 | ||
| EPS (TTM) (€) | -0.045 | ||
| Beta | -1.9139 | ||
| 3-Year Sharpe Ratio | 0.28 | ||
| 3-Year Sortino Ratio | 0.54 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | 0.1 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 0.1 - 0.1 | ||
| Shares Outstanding (Mil) | 127.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Octopus Biosafety Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Octopus Biosafety Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Octopus Biosafety Frequently Asked Questions
What is Octopus Biosafety(STU:OCR)'s stock price today?
The current price of STU:OCR is €0.10. The 52 week high of STU:OCR is €0.10 and 52 week low is €0.10.
When is next earnings date of Octopus Biosafety(STU:OCR)?
The next earnings date of Octopus Biosafety(STU:OCR) is .
Does Octopus Biosafety(STU:OCR) pay dividends? If so, how much?
Octopus Biosafety(STU:OCR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Octopus Biosafety
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers